Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -1.121M
March 31, 2026 -1.828M
December 31, 2025 -2.898M
September 30, 2025 -2.437M
June 30, 2025 -2.621M
March 31, 2025 3.01M
December 31, 2024 -7.181M
September 30, 2024 -1.091M
June 30, 2024 -0.60M
March 31, 2024 -0.829M
December 31, 2023 -1.487M
September 30, 2023 -5.256M
June 30, 2023 -5.764M
March 31, 2023 -4.407M
December 31, 2022 18.40M
September 30, 2022 -5.16M
June 30, 2022 -7.47M
March 31, 2022 -8.348M
Date Value
December 31, 2021 -13.82M
September 30, 2021 -23.53M
June 30, 2021 -14.27M
March 31, 2021 -12.48M
December 31, 2020 -12.68M
September 30, 2020 -8.822M
June 30, 2020 -4.311M
March 31, 2020 1.15M
December 31, 2019 -9.981M
September 30, 2019 -5.816M
June 30, 2019 -5.22M
March 31, 2019 -5.286M
December 31, 2018 -4.755M
September 30, 2018 -5.324M
June 30, 2018 -6.825M
March 31, 2018 -5.509M
December 31, 2017 -3.443M
September 30, 2017 -1.932M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. -17.80M
Century Therapeutics, Inc. -34.55M
Absci Corp. -33.21M
Celularity, Inc. 0.675M
Cardio Diagnostics Holdings, Inc. -1.502M

Net Income (Quarterly) Related Metrics